Common chemotherapy is not heart toxic in patients with BRCA1/2 mutations

Use of anthracycline-based chemotherapy, a common treatment for breast cancer, has negligible cardiac toxicity in women whose tumors have BRCA1/2 mutations — despite preclinical evidence that such treatment can damage the heart. —> Read More Here


Leave a Reply

Your email address will not be published. Required fields are marked *